Review article · 2017 · Open access
Evolution of Patient-Reported Outcomes and Their Role in Multiple Sclerosis Clinical Trials
Neurotherapeutics, 14(4), 934–944 · Published 14 September 2017 · DOI 10.1007/s13311-017-0571-6
In brief
“Evolution of Patient-Reported Outcomes and Their Role in Multiple Sclerosis Clinical Trials” is a 2017 review article by Cindy J. Nowinski and 2 co-authors, published in Neurotherapeutics. OpenAlex counts 77 citations as of 22 November 2026. It is open access: the full text is free to read at Neurotherapeutics.
- Citations
- 77
- Most cited in
- 2022 (15)
- Field-weighted impact
- 0.61
- References
- 131
- Authors
- 3
Cite this paper
Formatted from the catalogue record. Check names, capitals and page numbers against the paper before you submit.
APA 7
Nowinski, C. J., Miller, D. M., & Cella, D. F. (2017). Evolution of Patient-Reported Outcomes and Their Role in Multiple Sclerosis Clinical Trials. Neurotherapeutics, 14(4), 934–944. https://doi.org/10.1007/s13311-017-0571-6
MLA 9
Nowinski, Cindy J., et al. “Evolution of Patient-Reported Outcomes and Their Role in Multiple Sclerosis Clinical Trials.” Neurotherapeutics, vol. 14, no. 4, 2017, pp. 934–944. https://doi.org/10.1007/s13311-017-0571-6.
Chicago
Nowinski, Cindy J., Deborah M. Miller, and David F Cella. 2017. “Evolution of Patient-Reported Outcomes and Their Role in Multiple Sclerosis Clinical Trials.” Neurotherapeutics 14 (4): 934–944. https://doi.org/10.1007/s13311-017-0571-6.
Harvard
Nowinski, C. J., Miller, D. M. and Cella, D. F. (2017) ‘Evolution of Patient-Reported Outcomes and Their Role in Multiple Sclerosis Clinical Trials’, Neurotherapeutics, 14(4), pp. 934–944. doi:10.1007/s13311-017-0571-6.
IEEE
C. J. Nowinski, D. M. Miller, and D. F. Cella, “Evolution of Patient-Reported Outcomes and Their Role in Multiple Sclerosis Clinical Trials,” Neurotherapeutics, vol. 14, no. 4, pp. 934–944, 2017, doi: 10.1007/s13311-017-0571-6.
BibTeX
@article{nowinski2017evolution,
title = {{Evolution of Patient-Reported Outcomes and Their Role in Multiple Sclerosis Clinical Trials}},
author = {Nowinski, Cindy J. and Miller, Deborah M. and Cella, David F},
journal = {Neurotherapeutics},
year = {2017},
volume = {14},
number = {4},
pages = {934--944},
doi = {10.1007/s13311-017-0571-6},
url = {https://doi.org/10.1007/s13311-017-0571-6}
}
Download for a reference manager: BibTeX (.bib) · RIS for Zotero, Mendeley and EndNote (.ris)
Citations by year
| Year | Citations | Share of the best year |
|---|---|---|
| 2017 | 1 | |
| 2018 | 1 | |
| 2019 | 7 | |
| 2020 | 8 | |
| 2021 | 14 | |
| 2022 | 15 | |
| 2023 | 12 | |
| 2024 | 6 | |
| 2025 | 4 | |
| 2026 | 9 |
Its field-weighted citation impact is 0.61: it has been cited 0.61 times as often as the average work of the same field, type and year (1.00 is the world average).
Topic and keywords
Health Sciences › Medicine › Clinical Neurology › Multiple Sclerosis Research Studies
- patient-reported outcomes
- multiple sclerosis
- disease-modifying therapy
- health-related quality of life
- Neuro-QoL
- PROMIS
- daclizumab
- teriflunomide
Work with this paper
Most-cited papers in Medicine
- Yaşlı Kadınlarda Üreme SağlığıDemet Kokanalı, Yaprak Engin Üstün · Jinekoloji-Obstetrik ve Neonatoloji Tıp Dergisi · 2019 · 169,630 citations
- Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 CountriesHyuna Sung, Adalberto M. Filho, Mathieu Laversanne and 5 more · CA A Cancer Journal for Clinicians · 2021 · 119,885 citations
- “Mini-mental state”Marshal F. Folstein, Susan E. Folstein, Paul R. McHugh · Journal of Psychiatric Research · 1975 · 90,424 citations
- Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countriesFreddie Bray, Jacques Ferlay, Isabelle Soerjomataram and 3 more · CA A Cancer Journal for Clinicians · 2018 · 87,396 citations
- Hallmarks of Cancer: The Next GenerationDouglas Hanahan, Robert A. Weinberg · Cell · 2011 · 69,758 citations
Questions about this paper
How do I cite this paper in APA style?
Nowinski, C. J., Miller, D. M., & Cella, D. F. (2017). Evolution of Patient-Reported Outcomes and Their Role in Multiple Sclerosis Clinical Trials. Neurotherapeutics, 14(4), 934–944. https://doi.org/10.1007/s13311-017-0571-6
How many times has this paper been cited?
77 times, according to OpenAlex on 22 November 2026. Google Scholar and Scopus count different sets of sources, so their numbers differ.
Is this paper free to read?
Yes. It is open access at Neurotherapeutics: sign in and open the PDF from this page.
Who wrote this paper?
Cindy J. Nowinski, Deborah M. Miller, David F Cella.
What is the DOI of this paper?
10.1007/s13311-017-0571-6, permanently at https://doi.org/10.1007/s13311-017-0571-6. Sign in and open it from this page.
Bibliographic data from OpenAlex (CC0), last checked 22 November 2026. ResearchGuru does not host this paper; once you are signed in, the links open it at the publisher or the repository that does.